New Somatic Cancer Reference Standards Launched to Monitor Diagnostic Assay Accuracy
The standards developed through a public-private partnership contain seven oncogenic mutations selected for clinical significance.
Read MorePosted by CLP Edit Staff | Nov 24, 2025 | Cancer |
The standards developed through a public-private partnership contain seven oncogenic mutations selected for clinical significance.
Read MorePosted by CLP Edit Staff | Nov 21, 2025 | Company News |
The deal positions Abbott to enter the US cancer screening and precision oncology diagnostics market with products including Cologuard and Oncotype DX tests.
Read MorePosted by CLP Edit Staff | Nov 21, 2025 | Digital Pathology |
The self-service integration enables users to analyze tumor microenvironments at single-cell resolution using routine H&E slides.
Read MorePosted by CLP Edit Staff | Nov 20, 2025 | Prostate |
The whole-genome test combines data from 7 million genetic markers with clinical risk factors to provide individualized 10-year and lifetime risk assessments.
Read MorePosted by CLP Edit Staff | Nov 20, 2025 | Mass Spectrometry |
The system is designed to handle more than 10,000 injections without cleaning and scan over 900 SRM transitions per second for high-throughput laboratories.
Read More